NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the NAPLEX exam with a comprehensive quiz featuring multiple-choice questions and in-depth explanations. Build your pharmacological knowledge and increase your chances of passing the pharmacist licensure examination!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.


Which phosphate binder must not be used concurrently with levothyroxine?

  1. Sucroferric oxyhydroxides

  2. Ferric citrate

  3. Calcium acetate

  4. Sevelamer hydrochloride

The correct answer is: Sucroferric oxyhydroxides

Sucroferric oxyhydroxides must not be used concurrently with levothyroxine because it can bind to levothyroxine in the gastrointestinal tract and reduce its absorption. This can lead to decreased effectiveness of levothyroxine, which is used to treat hypothyroidism. On the other hand, the other options (Ferric citrate, Calcium acetate, Sevelamer hydrochloride) do not have a significant interaction with levothyroxine and can be used concurrently if needed.